These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7985487)

  • 21. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract]   [Full Text] [Related]  

  • 22. Antithrombin therapy for elective percutaneous coronary intervention: which agent to use? Does it matter?
    Brener SJ
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1092-4. PubMed ID: 19926049
    [No Abstract]   [Full Text] [Related]  

  • 23. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 24. [A trial of the use of low-molecular-weight heparin (fraksiparin) in myocardial infarct].
    Savenkov MP; Borshchevskaia MV; Gvozdkov AL; Semenova EN
    Ter Arkh; 1996; 68(8):8-12. PubMed ID: 9019842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Argatroban for anticoagulation in pediatric patients with heparin-induced thrombocytopenia requiring extracorporeal life support.
    Potter KE; Raj A; Sullivan JE
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):265-8. PubMed ID: 17414571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controversies in heparin monitoring.
    Zehnder J; Price E; Jin J
    Am J Hematol; 2012 May; 87 Suppl 1():S137-40. PubMed ID: 22495972
    [No Abstract]   [Full Text] [Related]  

  • 27. [Liver rupture of a subcapsular haematoma after pharmacologic revascularization (Streptokinase) for acute myocardial infarction--case report].
    Tomescu D; Vişan A; Popescu I; Tulbure D
    Chirurgia (Bucur); 2008; 103(5):577-82. PubMed ID: 19260636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare case of dermatitis herpetiformis requiring parenteral heparin for long-term control.
    Tan CC; Sale JE; Brammer C; Irons RP; Freeman JG
    Dermatology; 1996; 192(2):185-6. PubMed ID: 8829511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin calcium treated Henoch-Schönlein purpura nephritis in children through inhibiting hyperfibrinolysis.
    Tian M; Liu C
    Ren Fail; 2015 Aug; 37(7):1100-4. PubMed ID: 26133741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Medico-economic analysis of antithrombotic prophylaxis versus no prophylaxis in traumatology. Study of 920 cases].
    Güell Fortuny J; Torras Barba J; Pales Argullos A
    Angiologia; 1987; 39(1):1-8. PubMed ID: 3105363
    [No Abstract]   [Full Text] [Related]  

  • 31. Subcutaneous enoxaparin following thrombolysis and intravenous unfractionated heparin in ST-elevation acute myocardial infarction: safety and efficacy of low vs full dose.
    Rubboli A; Gatti C; Spinolo L; Parollo R; Spitali G; Maresta A
    Minerva Cardioangiol; 2006 Feb; 54(1):131-7. PubMed ID: 16467747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary thromboprophylaxis with heparins for arteriovenous fistula failure in pediatric patients.
    Sharathkumar A; Hirschl R; Pipe S; Crandell C; Adams B; Lin JJ
    J Vasc Access; 2007; 8(4):235-44. PubMed ID: 18161668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experiences with risk-adjusted thrombosis prevention in surgery].
    Stiegler H; Schürmann M
    Vasa Suppl; 1992; 35():101-2. PubMed ID: 1481007
    [No Abstract]   [Full Text] [Related]  

  • 35. [Liver toxicity from heparin].
    Barreiro López B; Canet JJ; Ochoa de Echaguen Aguilar A
    An Med Interna; 2000 Mar; 17(3):164. PubMed ID: 10804648
    [No Abstract]   [Full Text] [Related]  

  • 36. Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis.
    Górski G; Szopiński P; Michalak J; Marianowska A; Borkowski M; Geremek M; Trochimczuk M; Brotánek J; Sárník S; Seménka J; Wilkowski D; Noszczyk W
    Angiology; 2005; 56(1):9-17. PubMed ID: 15678251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of the extension of distal deep venous thrombosis. A randomized controlled trial with a 6-month follow-up].
    Belcaro G; Laurora G; Cesarone MR; De Sanctis MT; Incandela L; Dugall M; Mezzanotte L
    Minerva Med; 1997 Dec; 88(12):507-14. PubMed ID: 9540780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Subcutaneous calcium heparinate: a new heparin].
    Desrochers Y
    Union Med Can; 1975 May; 104(5):722-8. PubMed ID: 1136066
    [No Abstract]   [Full Text] [Related]  

  • 39. Antithrombotic effect of OP/LMWH by subcutaneous route in rats.
    Fantuz M; Milani R; Andriuoli G; Mastacchi R; Barbanti M
    Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):328-34. PubMed ID: 3767531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Internal medicine and surgical patients. When thrombosis prevention is mandatory].
    Stiefelhagen P
    MMW Fortschr Med; 2009 Oct; 151(44):16-8. PubMed ID: 19957468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.